Kexing's 770 million foray into real estate Pien Tze Huang's repeated defeats and repeated battles in the pharmaceutical industry's infrastructure business, how is it?

People in the city want to come out, and people outside the city want to go in
.

A news that Kexing invested 770 million yuan to establish a real estate company spread like wildfire

When many real estate developers are in a quagmire and struggling, why did Kexing and Pien Tze Huang enter the infrastructure industry one after another?

Behind the "infrastructure business" of pharmaceutical companies is the "blood-boosting" >

01

01

To build an industrial park, Pien Tze Huang starts a second investment

To build an industrial park, Pien Tze Huang starts a second investment

On January 19, Pien Tze Huang announced that it plans to invest in a new industrial park.
The estimated investment limit is no more than 4.
48 billion yuan, and the source is the company's self-raised funds
.

Among them, the construction investment of the Pien Tze Huang Great Health and Smart Manufacturing Park project is about 2.

According to public reports, in July 2012, the industrial park project planned to acquire 1,070 mu of land in Nanjing High-tech Industrial Park by way of transfer, with a total investment of about 1.
6 billion yuan
.

Among them, the first phase investment is about 1.

Regarding the reason for the proposed termination of the investment plan, Pien Tze Huang once said that the investment plan of the Pien Tze Huang Industrial Park at that time was demonstrated, but later due to changes in the market environment, the investment plan of the Industrial Park did not match expectations
.

The reasons for the termination include that the company's sales of generic drugs have not met expectations in recent years, and the company can solve the problem of insufficient production capacity faced by the company's sales of generic drugs through technical transformation and outsourcing

In this cooperation, it is also related to the former partner China Resources Pharma
.

China Resources Pharma and Pien Tze Huang officially broke up in August 2019.

In November 2011, Pien Tze Huang and China Resources Pharmaceutical Group announced their cooperation.
The two parties jointly invested 1 billion yuan to establish a joint venture company, of which Pien Tze Huang held 49% of the shares.
The company invested 8 general medicine products, and agreed to build an area of ​​about 300 acres in Zhangzhou The pharmaceutical industry park, and the introduction of China Resources Pharmaceutical's marketing management platform and channels to establish a complete marketing system
.

At that time, China Resources Pharma promised to develop the joint venture company into a scale enterprise with annual production and sales of 200 million yuan within 3 years, and develop the joint venture company into an annual production sales of over 2 billion yuan and a net profit of over 200 million yuan within 10 years.
business
.

On December 28, 2015, due to the postponement of the construction of related projects in the Pien Tze Huang Industrial Park, the company stated in its reply to the Shanghai Stock Exchange's inquiry announcement that due to the slow progress of the equity cooperation plan between China Resources Pharma and the Zhangzhou Municipal Government, the company could not take advantage of China Resources Pharma's marketing.
The system enhances the company's profitability
.

In recent years, Pien Tze Huang has faced difficulties such as slowdown in performance and diversification
.

The previously unfinished industrial park planning has been restarted, and this time it has also changed from the previous "one" to "two"

Talking about the reasons for the construction of the new industrial park, Pien Tze Huang said in the announcement: "The plant area, process layout and equipment production capacity can no longer meet the development needs of the company and the market, resulting in the company's expansion of production capacity is limited to a certain extent
.

"

"Big health" and "beauty" are the directions for the expansion of Pien Tze Huang's production capacity
.

According to Pien Tze Huang’s latest announcement, the product plan of Pien Tze Huang’s Big Health Smart Park Project is a series of products such as Compound Pien Tze Huang Lozenges, Compound Pien Tze Huang Ointment, Compound Pien Tze Huang Hemorrhoid Ointment, Yindan Pinggan Capsules,

"The company has not yet launched color cosmetics products, but considering the rapid growth of the color cosmetics market.
.
.
The future color cosmetics category is also an important breakthrough for the company's category expansion
.

" "Pien Tze Huang Health Beauty Park Project Feasibility Research Report" mentioned in
.
Pien Tze Huang is one of the few pharmaceutical companies that can achieve certain achievements in the field of cosmetics, and has now formed a number of cosmetic brands such as "Pien Tze Huang" and "Queen"
.

02

02

Is it a good business for pharmaceutical companies to enter real estate?

Is it a good business for pharmaceutical companies to enter real estate?

The development of cross-industry is not all smooth sailing, and some pharmaceutical companies have sold real estate at a loss
.

In April 2006, Yunnan Baiyao invested and established Yunnan Baiyao Real Estate with a registered capital of 10 million yuan, mainly engaged in urban construction investment, real estate development, building materials, decorative materials, machinery and equipment sales,
etc.
According to published data, in the five years since its establishment, Yunnan Baiyao's real estate company suffered losses most of the time, and its debt ratio in 2012 was as high as 98.
72%
.
5 years down the final loss of 440,000 yuan
.
In 2013, Yunnan Baiyao Group sold 100% of the real estate company, and it ended hastily
.

Seven years after withdrawing from the real estate market, in 2020, Yunnan Baiyao Group once again entered the real estate industry
.
On October 30, Yunnan Baiyao Group Shanghai Co.
, Ltd.
was established with a registered capital of 150 million yuan.
It is a wholly-owned subsidiary of Yunnan Baiyao Group Co.
,
Ltd.
Mainly engaged in real estate development and operation; various engineering construction activities; first-class medical equipment sales; enterprise management services and other businesses
.

Repeated defeats, repeated defeats
.
In June 2021, Yunnan Baiyao also issued the "Announcement on the Construction Plan of the Shanghai International Center Project", stating that Yunnan Baiyao invested in the construction of the Shanghai International Center project
.

In today’s real estate industry, Evergrande has transformed and Greenland has withdrawn, and many real estate companies are struggling.
In the first half of 2021, Kexing, which made a profit of about 50 billion yuan from the new crown vaccine, not only established a new whole company in October 2021.
Capital subsidiary, and two months later, the registered capital was increased to 770 million yuan
.
Is Sinovac ready to enter the real estate development field?

According to public information, Beijing Kexing Yidao Real Estate Co.
, Ltd.
was established with Yin Weidong as its legal representative and a registered capital of 770 million yuan.
Its business scope includes: real estate development and operation; property management; operation and management of motor vehicle public parking lots; enterprise management,
etc.
The company is 100% controlled by Beijing Kexing Zhongwei Biotechnology Co.
,
Ltd.

In the eyes of people in the real estate industry, Kexing entered the real estate field, relying on vaccines to earn "plenty" of cash flow, and "not bad money" is one of the main reasons
.
At the same time, some people speculate whether Kexing's move is a prelude to switching the track? In response to various speculations from the outside world, Kexing Bio responded that the above-mentioned companies mainly manage leased houses, mainly for employees' house leases and short-term accommodation of external experts who arrive irregularly
.